HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS - ANVISA Registration 10287411227

Access comprehensive regulatory information for HUMAN CHORIONIC GONADOTROPIN BETA (BHCG) - TUMOR MARKER/CONGENITAL DISORDERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411227 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until May 02, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including B-R-A-H-M-S GMBH, AUTOBIO DIAGNOSTICS CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.